InspireMD, Inc.

Analysis for Ticker: NSPR

Inspiremd Inc is a medical technology company that develops carotid stents like CGuard Prime to prevent strokes, but its internal mathematics has transformed it into a wealth extraction engine that is collapsing under its own weight. The company is attempting to sell 75,0$ million of new common stock through a broker named BTIG, which is a disaster for investors because of a hidden rule triggered by the stock price. Because the shares are trading at 1,15$, which is well below the 1,38$ threshold, a full-ratchet trapdoor has opened for the owners of Series C preferred stock. This rule forces the company to print and hand over extra shares for free to these preferred holders to make up for the lower price, creating a loop where every new sale triggers more free shares and further dilutes the value of everyone else. To keep this fire burning, they authorized an increase in their share limit from 150 million to 250 million shares.